Nurix Therapeutics (NRIX) Operating Income (2019 - 2026)
Nurix Therapeutics (NRIX) recorded Operating Income of -$94.2 million in fiscal Q2 2026 (quarter ended May 31, 2026), compared with -$48.32 million a year earlier.
Powered by 
Analysis
Nurix Therapeutics (NRIX) Operating Income (2019 - 2026) Analysis & Trends
On a TTM basis, Nurix Therapeutics' Operating Income came in at -$361.18 million as of May 31, 2026; for FY2025 (ended Nov 30, 2025), it came in at -$285.67 million.
- Across earlier fiscal years, Operating Income came in at -$213.03 million in FY2024, -$155.06 million in FY2023, -$183.87 million in FY2022 and -$117.89 million in FY2021.
- The fiscal Q2 2026 figure is the lowest quarterly Operating Income in data going back to fiscal Q3 2019.
- Per Business Quant, the preceding three fiscal quarters came in at -$92.5 million (Q1 2026), -$83.1 million (Q4 2025) and -$91.39 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 11.75 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 7.14 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 6.43 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | -584.00 Mn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 4.75 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 3.16 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 3.51 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | -10.39 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 4.27 Bn |
| 10 | Nurix Therapeutics | 2.90 Bn | 275.74 Mn | - | 559.45 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Aug 31, 2026 | 559.45 Mn |
| May 31, 2026 | -94.20 Mn |
| Feb 28, 2026 | -92.50 Mn |
| Nov 30, 2025 | -83.10 Mn |
| Aug 31, 2025 | -91.39 Mn |
| May 31, 2025 | -48.32 Mn |
| Feb 28, 2025 | -62.86 Mn |
| Nov 30, 2024 | -64.66 Mn |
| Aug 31, 2024 | -54.61 Mn |
| May 31, 2024 | -48.54 Mn |
| Feb 29, 2024 | -45.22 Mn |
| Nov 30, 2023 | -45.33 Mn |
| Aug 31, 2023 | -40.01 Mn |
| May 31, 2023 | -26.77 Mn |
| Feb 28, 2023 | -42.95 Mn |
| Nov 30, 2022 | -48.69 Mn |
| Aug 31, 2022 | -46.72 Mn |
| May 31, 2022 | -45.72 Mn |
| Feb 28, 2022 | -42.74 Mn |
| Nov 30, 2021 | -37.95 Mn |
API Access
Nurix Therapeutics Operating Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=operating-income&ticker=NRIX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "operating-income", "ticker": "NRIX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=operating-income&ticker=NRIX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();